Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

Medtronic launches FDA-cleared guidewire compatible with multiple TAVR systems
The guidewire was built specifically with Medtronic's own Evolut platform in mind. However, it is also compatible with all other commercially available TAVR systems.
'The less you drink, the better': Even minor changes in alcohol use lower hypertension risk
These new findings challenge the long-standing assumption that low levels of alcohol do not meaningfully influence a person's blood pressure.
New biodegradable PFO closure device shows early potential
Researchers tracked patients for two years, using echocardiography to confirm the devices had completely vanished. Additional studies will still be required.
Cardiology groups among the voices concerned about more medical device tariffs
When the Trump administration requested public input on adding more tariffs for PPE and all medical devices, hundreds of public comments were submitted. One common concern among those responses is that healthcare providers could be left with significantly higher costs.
Collaborations, guidelines and grants: ASNC shares big plans for 2026
American Society of Nuclear Cardiology President-elect Jamieson M. Bourque, MD, detailed just some of what the group has planned for 2026. For example, ASNC will be working on the development of multiple new guidelines designed to help clinicians provide high-quality care.

ACC President Cathie Biga explains how cardiologist employment models undergoing a profound transformation during an interview with Cardiovascular Digital Editor Dave Fornell at ACC 2024.

What happened to cardiology's private practices?

Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology

The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients.

First-in-Man Experience of Robotic-Assisted Transcatheter Edge-to-Edge Repair With Pure Echo Guidance

Cardiologists and surgeons perform world’s first robot-assisted TEER

A 62-year-old women presented with severe MR and recurrent heart failure episodes. Initial data suggest the procedure was a success.

Sunil Rao, MD, NYU, explains the DANGER-SHOCK trial at ACC 2024 and how it may help improve cardiogenic shock survival.

Cardiologist Sunil Rao highlights importance of DanGer Shock compared to other cardiogenic shock trials

Sunil Rao, MD, director of interventional cardiology at NYU Langone, says DanGer Shock is a "very, very important study" when it comes to the treatment of cardiogenic shock.

cardiologists going through the certification process

SCAI 2024 Scientific Sessions to focus on TAVR, PAD and other key trends in interventional cardiology

Interventional cardiologists from all over the world will gather for three days of educational sessions, late-breaking presentations, live cases and more. The festivities begin Thursday, May 2, in Long Beach, California.

doctor patient discharge after heart surgery

Next-day discharge after TAVR with a self-expanding valve: 4 key takeaways

Researchers explored STS/ACR data from nearly 30,000 TAVR patients, presenting their findings in the Journal of the American Heart Association.

Society of Thoracic Surgeons launches new risk calculators for SAVR after TAVR, other key heart surgeries

STS risk calculators are known as a go-to resource for cardiologists, surgeons and any other healthcare providers who manage the care of heart patients.

An 86-year-old patient is showing signs of improvement six months after receiving the world’s first implant of a new-look medical device for treating tricuspid regurgitation (TR), according to new data published in JACC: Cardiovascular Interventions.[1] The device in question, the Tricuspid Flow Optimizer, was developed by Triflo Cardiovascular, a U.S.-based biomedical company founded in 2017 by a team of structural heart specialists.

Cardiologists share update after world’s first implant of new optimizer device for tricuspid regurgitation

The Tricuspid Flow Optimizer was developed by Triflo Cardiovascular, a U.S.-based healthcare technology company founded by structural heart specialists.

Cardiology Associations

Medtronic launches FDA-cleared guidewire compatible with multiple TAVR systems

'The less you drink, the better': Even minor changes in alcohol use lower hypertension risk

New biodegradable PFO closure device shows early potential

Cardiology groups among the voices concerned about more medical device tariffs

Collaborations, guidelines and grants: ASNC shares big plans for 2026